- Home
- STG vs ASMB Comparison
STG vs ASMB Comparison
Compare STG & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STG
- ASMB
- Stock Information
- Founded
- STG 2003
- ASMB 2005
- Country
- STG China
- ASMB United States
- Employees
- STG N/A
- ASMB N/A
- Industry
- STG Other Consumer Services
- ASMB Biotechnology: Pharmaceutical Preparations
- Sector
- STG Real Estate
- ASMB Health Care
- Exchange
- STG Nasdaq
- ASMB Nasdaq
- Market Cap
- STG 73.4M
- ASMB 141.8M
- IPO Year
- STG 2018
- ASMB 2010
- Fundamental
- Price
- STG $11.25
- ASMB $18.85
- Analyst Decision
- STG
- ASMB Strong Buy
- Analyst Count
- STG 0
- ASMB 3
- Target Price
- STG N/A
- ASMB $33.00
- AVG Volume (30 Days)
- STG 53.4K
- ASMB 42.4K
- Earning Date
- STG 08-15-2025
- ASMB 08-07-2025
- Dividend Yield
- STG N/A
- ASMB N/A
- EPS Growth
- STG N/A
- ASMB N/A
- EPS
- STG 3.09
- ASMB N/A
- Revenue
- STG $269,356,990.00
- ASMB $32,154,000.00
- Revenue This Year
- STG N/A
- ASMB $0.04
- Revenue Next Year
- STG N/A
- ASMB N/A
- P/E Ratio
- STG $4.15
- ASMB N/A
- Revenue Growth
- STG N/A
- ASMB 148.33
- 52 Week Low
- STG $4.25
- ASMB $7.75
- 52 Week High
- STG $15.00
- ASMB $19.93
- Technical
- Relative Strength Index (RSI)
- STG 79.59
- ASMB 68.23
- Support Level
- STG $7.07
- ASMB $17.93
- Resistance Level
- STG $15.00
- ASMB $19.11
- Average True Range (ATR)
- STG 1.19
- ASMB 0.82
- MACD
- STG 0.75
- ASMB -0.03
- Stochastic Oscillator
- STG 76.96
- ASMB 89.76
About STG Sunlands Technology Group
Sunlands Technology Group is a provider of online post-secondary and professional education services in China. The company offers various degree- and diploma-oriented post-secondary courses through its online platforms. In addition, it provides online professional courses and educational content to help students prepare for professional certification exams and attain professional skills. The Group has one operating segment, which is the provision of online education services.
About ASMB Assembly Biosciences Inc.
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.